ASHG 2026 · Biopharma
LAM Therapeutics at ASHG 2026
Boston, Massachusetts
LAM Therapeutics at ASHG 2026 in Montréal: 2 presentations (2 posters); Booth 1302.
2
presentations on the program
1302
exhibit booth
| Organization | ASHG 2026 Attendance |
|---|---|
LAM Therapeutics Boston, Massachusetts | 1 Associate Scientist · 1 other presenter |
Zevra develops and commercializes therapeutics for rare diseases, serving patients with limited or no treatment options.
| Booth Exhibiting at Booth 1302 Wed, Oct 219:45am–4:30pmThu, Oct 229:45am–1:30pmFri, Oct 239:45am–4:30pm Poster Fri Oct 23 2:30 pm X-Cell: A High-Capacity Generative Framework for Systematic, In Silico Mapping of Causal Gene Functions Artificial intelligenceGenome editing/CRISPRGenomicsPrecision medicine Poster Fri Oct 23 2:30 pm Analysis of NPC1 Genotypes: Findings from the US Arimoclomol Early Access Program for Niemann-Pick Disease Type C Lysosomal diseasesBrain/nervous systemNervous system |
Meeting LAM Therapeutics in Montréal?
Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction